Dr. Nana Kutateladze, MD

Dr. Kutateladze practices at University of Maryland Baltimore Washington Medical Center in Glen Burnie, Maryland, part of University of Maryland Medical System.

Dr. Kutateladze's NPI, 1720264914, was assigned on January 17, 2008. Dr. Kutateladze holds Delaware license C1-0008503.

Dr. Kutateladze's primary practice is University of Maryland Baltimore Washington Medical Center, at 301 Hospital Drive, Glen Burnie, MD 21061 in Anne Arundel County. The practice phone is (410) 595-1967.

Dr. Kutateladze's primary practice is University of Maryland Baltimore Washington Medical Center in Glen Burnie, Maryland, part of University of Maryland Medical System. Dr. Kutateladze is also affiliated with University of Maryland Medical Center. The medical group on file is Adfinitas Health. Dmand AI also links Dr. Kutateladze to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kutateladze practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kutateladze's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kutateladze is licensed in Delaware.

CMS data shows 1,179 Medicare services from Dr. Kutateladze across 5 procedure codes in 2024, for 510 Medicare patients. Medicare paid $105,877 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 510 Medicare patients who saw Dr. Kutateladze in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kutateladze's median patient age at 68, with 53% women.

In 2024, Dr. Kutateladze wrote 222 Medicare Part D claims for 107 patients. 88% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $162 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

Dr. Kutateladze accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Kutateladze from 3 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $91.